AlloVir
Vikas Sinha is the President and CFO at AlloVir, an ElevateBio Company. Prior to this role, Vikas served as the Chief Financial Officer at ElevateBio. Vikas Sinha holds an MBA from the Asian Institute of Management.
This person is not in any offices
AlloVir
AlloVir, formerly ViraCyte, was founded in 2013 and is the leader in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems.